Close X
Attorney Spotlight

What colorful method does Claire Miley use to keep up with the latest healthcare regulations as they relate to proposed transactions? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

On December 1, 2016, Parker Hannifin Corporation and CLARCOR Inc. announced that the companies have entered into a definitive agreement under which Parker will acquire CLARCOR for approximately $4.3 billion in cash, including the assumption of net debt. The transaction has been unanimously approved by the board of directors of each company. Upon closing of the transaction, expected to be completed by or during the first quarter of Parker’s fiscal year 2018, CLARCOR will be combined with Parker’s Filtration Group to form a leading and diverse global filtration business. Bass, Berry & Sims has served CLARCOR as primary corporate and securities counsel for 10 years and served as lead counsel on this transaction. Read more here.

CLARCOR
Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Securities Law Exchange BlogSecurities Law Exchange blog offers insight on the latest legal and regulatory developments affecting publicly traded companies. It focuses on a wide variety of topics including regulation and reporting updates, public company advisory topics, IPO readiness and exchange updates including IPO announcements, M&A trends and deal news.

Read More >

Steps

Products Liability & Torts

During the past 20+ years our firm has vigorously and successfully defended companies involved in a multitude of major mass tort litigation, including benzene, asbestos, fen-phen, Zyprexa, breast implants, artificial heart valves, pedicle screw spinal implants, PPA, Omniflox and Prozac, just to name a few. Our attorneys are quickly able to grasp the legal complexities involved in these cases, along with the medical and scientific issues, and have great success in retaining outstanding experts who can work at the national level to aid in the identification of relevant literature and assist in the defense of these cases.

We handle a wide variety of complex mass tort litigation, MDLs (multi-district litigations), and class actions, as well as serious individual suits alleging personal injury and/or economic loss against manufacturers. We also assist our clients with recalls, product withdrawals and regulatory actions with the Food and Drug Administration (FDA) and other agencies. We frequently consult with clients regarding warranties, contracts, indemnities and insurance coverage for products liability claims, as well as False Claim Act (FCA) matters and internal investigations. We employ the latest technology to manage large volumes of cases effectively and efficiently, including the use of a secure and free extranet to manage documents and other case information.

During the past 20+ years our firm has vigorously and successfully defended companies involved in a multitude of major mass tort litigation, including benzene, asbestos, fen-phen, Zyprexa, breast implants, artificial heart valves, pedicle screw spinal implants, PPA, Omniflox and Prozac, just to name a few. Our attorneys are quickly able to grasp the legal complexities involved in these cases, along with the medical and scientific issues, and have great success in retaining outstanding experts who can work at the national level to aid in the identification of relevant literature and assist in the defense of these cases.

We handle a wide variety of complex mass tort litigation, MDLs (multi-district litigations), and class actions, as well as serious individual suits alleging personal injury and/or economic loss against manufacturers. We also assist our clients with recalls, product withdrawals and regulatory actions with the Food and Drug Administration (FDA) and other agencies. We frequently consult with clients regarding warranties, contracts, indemnities and insurance coverage for products liability claims, as well as False Claim Act (FCA) matters and internal investigations. We employ the latest technology to manage large volumes of cases effectively and efficiently, including the use of a secure and free extranet to manage documents and other case information.

The cases we handle for manufacturers cross all industry groups, including:

  • Asbestos
  • Automotive
  • Chemical
  • Consumer products
  • Electronic devices
  • Food and beverage
  • Medical devices
  • Pharmaceuticals
  • Supplements
  • Telecommunications, and
  • Tractors and farming equipment.

We have had great success in getting cases dismissed early or postured for an early and favorable settlement through summary judgment, motions to dismiss, and/or favorable testimony obtained through depositions or the discovery process. However, we are trial lawyers in addition to litigators, and we are prepared to take the case all the way to trial if necessary. At the same time, we recognize the importance of early attempts to resolve litigation, through mediation or otherwise. To that end, we are familiar with and employ all methods of alternative dispute resolution to meet our clients' objectives.

We serve as national counsel, discovery counsel, expert counsel, regional counsel, and local counsel depending upon the client's needs and desires. We are experienced at working with regional and national counsel in order to fashion a global strategy for the resolution of multiple cases involving the same product. However, our litigation practice knows no geographical boundaries: we have lawyers licensed to practice in many states and we also work with many local firms to assist our clients.

+ Read More

- Read Less

News

View More

Related Experiences

View More

Related Professionals

NAME TITLE TELEPHONE CONTACT

Viewing 0 of 0 Results

View More

Publications

View More

Past Events

View More

Services

×

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.